EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study

Sandesh Rimal iD, Sabin Shrestha iD, Kishor Pandey iD, Thanh Vu Nguyen iD, Parmananda Bhandari, Yogendra Shah, Dhiraj Acharya, Nabaraj Adhikari, Komal Raj Rijal iD, Prakash Ghimire iD, Yuki Takamatsu, Basu Dev Pandey iD und 4 weitere

Viruses · 2023

DOI: 10.3390/v15020507 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Viruses, 2023. Verfasst von Sandesh Rimal und 15 weiteren Autor:innen. Beteiligte Einrichtung: Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal. Hauptthemen laut MEDLINE: Dengue Virus, Dengue. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Higher Education Reform Project (HERP) DLI -7B Research Grant, Nepal” and the “Japan Agency of Medical Research and Development (AMED)”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The largest dengue outbreak in the history of Nepal occurred in 2022, with a significant number of casualties. It affected all 77 districts, with the nation’s capital, Kathmandu (altitude 1300 m), being the hardest hit. However, the molecular epidemiology of this outbreak, including the dengue virus (DENV) serotype(s) responsible for this epidemic, remain unknown. Here, we report the epidemic trends, clinico-laboratory features, and virus serotypes and their viral load profiles that are associated with this outbreak in Nepal. Dengue-suspected febrile patients were investigated by routine laboratory, serological, and molecular tools, including a real-time quantitative polymerase chain reaction (qRT-PCR). Of the 538 dengue-suspected patients enrolled, 401 (74.5%) were diagnosed with dengue. Among these dengue cases, 129 (32.2%) patients who required hospital admission had significant associations with myalgia, rash, diarrhea, retro-orbital pain, bleeding, and abdominal pain. DENV-1, -2, and -3 were identified during the 2022 epidemic, with a predominance of DENV-1 (57.1%) and DENV-3 (32.1%), exhibiting a new serotype addition. We found that multiple serotypes circulated in 2022, with a higher frequency of hospitalizations, more severe dengue, and more deaths than in the past. Therefore, precise mapping of dengue and other related infections through integrated disease surveillance, evaluation of the dynamics of population-level immunity and virus evolution should be the urgent plans of action for evidence-based policy-making for dengue control and prevention in the country.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusDengueHumansCross-Sectional StudiesNepalSerogroupDisease Outbreaks

Stichwörter der Autor:innen

Nepaldengue outbreak 2022dengue serotypesdengue virusmultiple serotypes

Autor:innen und Institutionen

  • Central Department of Microbiology, Tribhuvan University, Kathmandu 44601, Nepal.
  • Central Department of Zoology, Tribhuvan University, Kathmandu 44601, Nepal.
  • Institute of Tropical Medicine, DEJIMA Infectious Disease Research Allience, Nagasaki University, Nagasaki 852-8523, Japan.
  • Sukraraj Tropical and Infectious Diseases Hospital, Teku, Kathmandu 44600, Nepal.
  • Seti Provincial Hospital, Kailali 10900, Nepal.
  • Cleveland Clinic, Florida Research and Innovation Center, Port Saint Lucie, FL 34987, USA.

ORCID-Profile: Sandesh Rimal, Sabin Shrestha, Kishor Pandey, Thanh Vu Nguyen, Komal Raj Rijal, Prakash Ghimire, Basu Dev Pandey, Shyam Prakash Dumre

Förderung

  • “Higher Education Reform Project (HERP) DLI -7B Research Grant, Nepal” and the “Japan Agency of Medical Research and Development (AMED)”

Zitieren

APA

Rimal, S., Shrestha, S., Pandey, K., Nguyen, T. V., Bhandari, P., Shah, Y., Acharya, D., Adhikari, N., Rijal, K. R., Ghimire, P., Takamatsu, Y., Pandey, B. D., Fernandez, S., Morita, K., Ngwe Tun, M. M., & Dumre, S. P. (2023). Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study. Viruses. https://doi.org/10.3390/v15020507

Vancouver

Rimal S, Shrestha S, Pandey K, Nguyen TV, Bhandari P, Shah Y, et al. Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study. Viruses. 2023. doi:10.3390/v15020507

BibTeX
@article{Rimal2023,
  author = {Rimal, Sandesh and Shrestha, Sabin and Pandey, Kishor and Nguyen, Thanh Vu and Bhandari, Parmananda and Shah, Yogendra and Acharya, Dhiraj and Adhikari, Nabaraj and Rijal, Komal Raj and Ghimire, Prakash and Takamatsu, Yuki and Pandey, Basu Dev and Fernandez, Stefan and Morita, Kouichi and Ngwe Tun, Mya Myat and Dumre, Shyam Prakash},
  title = {Co-Circulation of Dengue Virus Serotypes 1, 2, and 3 during the 2022 Dengue Outbreak in Nepal: A Cross-Sectional Study},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15020507}
}
Kostenlos starten →